a website banner telling users to subscribe to it's newsletter

Breaking News

Researchers Introduce Algae-Derived Solution for Retinal Detachment
Researchers Introduce Algae-Derived Solution for Retinal Detachment Mar 26, 2024 A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae.
Scientists Develop Healing Contact Lenses for Quicker Corneal Recovery
Scientists Develop Healing Contact Lenses for Quicker Corneal Recovery Mar 22, 2024 Waterloo scientists have developed groundbreaking contact lenses that both protect corneal wounds and deliver healing drugs.
Purdue Engineering Team to Develop Smart Contacts with $6.7M NIH Grant
Purdue Engineering Team to Develop Smart Contacts with $6.7M NIH Grant Mar 21, 2024 Research teams, under the guidance of a faculty member from Purdue University’s College of Engineering, have been awarded two grants from the National Eye Institute totaling $6.7 million.

 

Industry News

Provectus Secures Global Licensing Agreement for Eye Infection Treatment
Provectus Secures Global Licensing Agreement for Eye Infection Treatment Mar 28, 2024 Provectus Biopharmaceuticals has signed an exclusive global licensing agreement with the University of Miami to harness the University’s pioneering photodynamic antimicrobial therapy for combating (acanthamoeba) eye infections.
Don't Miss Out: ASCRS Congress 2024 Kicks Off This April 5-8
Don't Miss Out: ASCRS Congress 2024 Kicks Off This April 5-8 Mar 28, 2024 From April 5 to 8, 2024, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting is set to take place in Boston, USA, at the Boston Convention & Exhibition Center.
ABVC BioPharma Announces Global Licensing Agreement with ForSeeCon
ABVC BioPharma Announces Global Licensing Agreement with ForSeeCon Mar 28, 2024 ABVC BioPharma, Inc. has entered into a significant global licensing agreement with ForSeeCon Eye Corporation, marking a pivotal moment for the clinical-stage biopharmaceutical company known for its developments in ophthalmology, CNS, and oncology.

Ophthalmic Research News

New Study Opens Pathways for Treating Zika Virus-Induced Eye Abnormalities
New Study Opens Pathways for Treating Zika Virus-Induced Eye Abnormalities Mar 29, 2024 Researchers at Wayne State University School of Medicine have published a study in the journal iScience, shedding light on the potential treatment targets for eye abnormalities caused by the Zika virus (ZIKV) infection during pregnancy.
Regenxbio's Gene Therapy for Wet AMD Shows Promising Results in The Lancet
Regenxbio's Gene Therapy for Wet AMD Shows Promising Results in The Lancet Mar 29, 2024 Regenxbio Inc. announced the publication of their phase 1/2a study results in The Lancet, showcasing the effectiveness of ABBV-RGX-314 as a one-time gene therapy for wet age-related macular degeneration (AMD).
First Canadian Patient Dosed in Aurion’s Cell Therapy Trial for Corneal Edema
First Canadian Patient Dosed in Aurion’s Cell Therapy Trial for Corneal Edema Mar 29, 2024 Aurion Biotech recently administered its novel cell therapy, AURN001, to the first Canadian participant in the ABA-1, CLARA phase 1/2 clinical trial, targeting the treatment of corneal edema caused by corneal endothelial dysfunction.

Ophthalmic Blog

Revolutionizing Eye Care: The Role of 3D Printing Today and Tomorrow
Revolutionizing Eye Care: The Role of 3D Printing Today and Tomorrow Mar 28, 2024 The ability of 3D bioprinting to fabricate complex tissue constructs holds the promise of overcoming limitations in current treatments and enhancing patient outcomes.
The Serious Impact of Smoking on Your Eye Health
The Serious Impact of Smoking on Your Eye Health Mar 25, 2024 Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, stroke as well as eye diseases.
Report Exposes Lack of Support for Blind and Partially Sighted in England
Report Exposes Lack of Support for Blind and Partially Sighted in England Mar 22, 2024 A Freedom of Information (FOI) request has brought to light a concerning issue: thousands of blind and partially sighted individuals in England are being denied essential rehabilitation services.
Ophthalmology Breaking News Subscribe